Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

What is Immunochemotherapy?

Acidosis and Tumor Progression

The Cancer Cell Surface Proteome as a Therapeutic Target

Transforming Cancer Care through Genomic Testing

Cancer Research

Hot vs Cold: the differences between tumor types

Using Biomarkers to Detect Cancer

The Effects of Cancer on Family Life

Cancer Pain

What is Cancer?

What Causes Cancer?

See more featured articles »

Myc Mutations and Cancer

Assay for Monitoring and Treating Malignant Brain Tumors

Secondary Brain Cancer

Caring for a Loved One with Cancer

What is the Tumor Microenvironment?

Exploiting Enzymes in Cancer Diagnosis and Therapy

Extracellular Vesicles as Floating Cancer Biomarkers

What is Merkel Cell Carcinoma?

Cancer Pathophysiology

Cancer Prevention: Lowering your Risk

Cancer Prognosis

Living with Cancer Pain

TARDIS: The Improved Method of Detecting Breast Cancer

What is Cancer of Unknown Primary?

What is Tumorigenesis?

Hypoxia Markers and Their Importance

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Cancer Glossary

Effects of Social and Economic Deprivation on Cancer Mortality

The Biochemistry of Breast Cancer Screening

Investigating the Molecular Mechanisms of Cancer

British Pioneers in Cancer Biology

Cancer Pain Management

Overview of Cell Viability and Cytotoxicity

Is Cancer a Metabolic Disorder?

Microfluidic cancer treatment screen combined with flow cytometry

Insight into Cancer Vaccines

Metastatic Migration in Cancer may be Influenced by Metabolism

What Role do Biobanks Play in Cancer Research?

Cancer Epidemiology

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Cutaneous Manifestations of Internal Malignancy

Cancer Symptoms

Why are Cancer Cell Lines Useful?

Cancer History

Cancer Screening Considerations: Balancing the Benefits and Risks

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

CDK9 and Cancer

Cancer Classification

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Insights into Oncofertility

Secondary Lung Cancer

Pediatric Cancer

Cancer Diagnosis

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Targeted Cancer Therapies

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cancer Management

Latest Cancer News and Research

Study reveals continued care delays among patients with young-onset breast cancer

In an analysis of data on adolescents and young adults with breast cancer, lower income and younger age were linked with delays in care.

12 Oct 2026

Amphista Therapeutics announces first patient dosed in AMX-883 Phase 1 clinical trial for acute myeloid leukemia

Amphista Therapeutics Limited ('Amphista'), a leader in the discovery and development of non-cereblon / VHL targeted protein degradation (TPD) medicines, today announced dosing of the first patient in a Phase 1 trial for its lead candidate, AMX-883. Initiated following authorization from the U.S. Food and Drug Administration in June 2026, the BRAMLIE trial will investigate the safety, pharmacokinetics, and preliminary efficacy of AMX-883 monotherapy in participants with AML and high-risk MDS.

From Amphista Therapeutics 12 Oct 2026

HPV vaccines protect against cancer. Could they benefit pregnancy?

Findings from a nationwide study suggest HPV vaccination may reduce adverse pregnancy outcomes, emphasizing its importance in reproductive health strategies.

12 Oct 2026

Adding a chatbot to specialist care helped young people make sense of cancer risk

In a randomized trial of 106 adolescents and young adults with hereditary cancer predisposition, adding AYA-RISE to a clinic visit improved knowledge of cancer risk before age 30 compared with a clinic visit alone. Researchers observed no increase in distress, but the main analyses did not establish additional benefits for lifetime-risk or screening knowledge.

12 Oct 2026

What people ate at the start of a 20-year study was linked to their heart failure odds

Researchers linked higher baseline diet quality to lower odds of developing heart failure over 20 years among 2,159 Greek adults initially free of cardiovascular disease. Healthy-food consumption showed the most consistent association, but the observational study cannot establish that dietary changes prevent heart failure.

11 Oct 2026

Better blood pressure control could prevent over 518,000 annual deaths worldwide

Effective management of high blood pressure could prevent more than 518,000 annual deaths from cardiovascular disease around the world, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2026.

11 Oct 2026

A trial of 3,220 smokers puts cash rewards for quitting to the test

In a randomized trial of 3,220 medically underserved adults referred for lung cancer screening, adding financial incentives to usual care and free medication increased sustained smoking abstinence at six months. Offering free medication alone did not significantly increase quit rates, and adding a forward-looking mobile tool did not improve outcomes beyond the incentives.

11 Oct 2026

Scientists identify the neuroblastoma cells that signal poor outcomes

Neuroblastoma is the most common solid tumor found outside of the brain in children, yet why some children respond well to treatment while others do not has remained poorly understood.

10 Oct 2026

n6 expands global distribution footprint, bringing iconPCR™ and AutoNorm to more scientists across Europe, the Middle East, and Africa

n6, maker of the icon96™ and icon16 thermocyclers powered by iconPCR™ with AutoNorm intelligent normalization technology for next‑generation sequencing (NGS) library preparation, today announced new and expanded distribution partnerships that significantly increase access to its instruments across Europe, the Middle East, and Africa.

From n6 10 Oct 2026

Global survey finds gaps in pediatric cardiac troponin testing

Cardiac troponin, a protein released into the blood when heart muscle is damaged, can be used as a quick measure of heart injury in adults, and testing for it has revolutionized adult cardiology. For children, however, doctors often lack data on normal troponin measurements.

9 Oct 2026

Polymeric nanomedicine strategies improve solid tumor immunotherapy outcomes

Solid tumors are not merely collections of malignant cells but complex ecosystems comprising tumor cells, stromal cells, and the extracellular matrix (ECM).

9 Oct 2026

Real time molecular movie unlocks secrets of penicillin biosynthesis

Researchers from the University of Oxford and international collaborators have revealed previously unseen rapid chemical stages in the formation of β-lactam antibiotics like penicillin, offering insights that can support future antibiotic development.

9 Oct 2026

FDA approves atezolizumab combination for stage III colon cancer with deficient DNA mismatch repair

The Alliance for Clinical Trials in Oncology (Alliance) today announced that the U.S. Food and Drug Administration has approved the immunotherapy drug atezolizumab (Tecentriq) in combination with fluoropyrimidine and oxaliplatin chemotherapy, for the adjuvant treatment of patients with stage III colon cancer with deficient deoxyribonucleic acid (DNA) mismatch repair (dMMR).

9 Oct 2026

Study explains why cancer immunity declines faster in males

Lutz Menzel, PhD, formerly of the Department of Radiation Oncology within the Mass General Brigham Cancer Institute, and Tim Padera, PhD, currently of the Mass General Brigham Cancer Institute, are the lead and senior authors of a paper published in Nature Aging, "Lymph node contraction links sex-biased naive CD8 T cell decline to compromised antigen recognition during middle age."

9 Oct 2026

Lynch syndrome patients rarely use aspirin for cancer prevention

According to international studies, taking Acetylsalicylic acid daily can protect people with Lynch syndrome from developing colorectal cancer - even at low doses. Researchers from the University Hospital Bonn (UKB), the University of Bonn, and the Center for Integrated Oncology (CIO) Bonn, in collaboration with the self-help organization SemiColon, have now found that these scientific findings have so far been insufficiently incorporated into clinical practice.

9 Oct 2026

Oncopeptides confirms blood-brain-barrier penetration based on data from first patients in glioblastoma Window-of-Opportunity (WoO) study

Oncopeptides AB (publ), a biotech company specializing in difficult-to-treat cancers, today announces data from the first patients in its ongoing clinical Window-of-Opportunity (WoO) study, OP-701 (INSULA), evaluating its proprietary Peptide Drug Conjugate (PDC) platform in glioblastoma.

9 Oct 2026